Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.40 -0.39% 1,623.40 1,623.20 1,623.60 1,634.20 1,622.20 1,627.40 1,471,884 10:18:30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 17.3 80,599

Glaxosmithkline Share Discussion Threads

Showing 19376 to 19397 of 20825 messages
Chat Pages: Latest  785  784  783  782  781  780  779  778  777  776  775  774  Older
DateSubjectAuthorDiscuss
27/2/2019
15:08
Could see GSK falling to 14.50
zicopele
27/2/2019
15:07
Ess Yes if thats happens GSK 1465p
montyhedge
27/2/2019
14:51
Mentioned a few times I thought there was significant upside to GBP against USD/EURO as leaving Without a deal was unlikely. That now looks underway. Would not surprise me to see GBP/EURO at 1.25 plus, and would not rule at comfortably over 1.30 in time. 1.37/8 area on cable.
essentialinvestor
27/2/2019
12:06
what a dog this share is, bring back the old management.
porsche1945
26/2/2019
17:43
Pound two year high, FTSE 100, 70% of companies are dollar earners.
montyhedge
26/2/2019
13:33
Could be heading to test 1480p, although a strengthening £ could see the share price heading lower, to test the next support area 1430p
ny boy
26/2/2019
11:43
Disagree. GSK is a short term currency play. Mathematics. (Of course there are business factors too).
alphorn
26/2/2019
11:38
Rock star - whether "you" believe in Brexit is irrelevant. It's the old saying, it's not what you think, it's what you think other people think.
grahamite2
26/2/2019
11:34
"U.S. healthcare stocks may face some turbulence today as leaders from the largest pharmaceutical companies get grilled on Capitol Hill over the high cost of prescription drugs" The congressional hearing, called "Drug Pricing in America: A Prescription for Change, Part II," is reminiscent of previous encounters with businesses that proved to be turning points, leading to massive reforms on Wall Street, the health insurance industry and tobacco companies.
wbecki
26/2/2019
10:15
Dollars earners are about 70% of the FTSE 100 on some kind of Brexit deal, markets falls 10% on no deal market up 10%. I say down on a deal.
montyhedge
26/2/2019
10:00
No Brexit GSK up on weak sterling, if a deal, strong sterling I see GSK 1476p my view. Dollar earners would be hit.
montyhedge
26/2/2019
09:24
GSK is a currency play. If you don’t believe in a hard brexit then it will go down.
rock star
26/2/2019
08:37
how are you getting on pumping iag monty? ;-)
nimbo1
26/2/2019
08:25
IN @ 1518.90 …..;0)
tradermichael
26/2/2019
08:20
Like I said income investors jumped in for the dividend, traders will get this below psychological level of 1500p.
montyhedge
22/2/2019
12:23
Had forgotten all about this... "SFO close their investigation" In reference to the announcement issued by the Serious Fraud Office ("SFO") today, GlaxoSmithKline plc (LSE/NYSE: GSK) is pleased that the SFO have closed their investigation and concluded that no further action is required. hTTps://www.investegate.co.uk/glaxosmithkline-plc/gsk/gsk-response-to-sfo-statement/201902221121488883Q/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=GlaxoSmithKline%20PLC%20Alert The SFO was looking into alleged bribery in China disclosed by a whistleblower. hTTps://seekingalpha.com/news/3436100-uk-fraud-watchdog-closes-glaxo-investigation#email_link
wbecki
22/2/2019
12:06
Dividend is not too high, cover by strong cash flow is good now. You're regurgitating old analysis that is long since irrelevant.
romeike
22/2/2019
11:49
So UBS have cut the target price by 3% and downgraded.Unlikely to drum up enough business to fund their forthcoming fine.
steeplejack
22/2/2019
10:45
I guess UBS is not optimistic. We t too high and dividend too high.
zicopele
22/2/2019
10:42
FWIW Downgrade from UBS 'buy' to 'neutral' .. tp 1650p cut from 1700p
philanderer
22/2/2019
09:04
Thanks, nimbo1 ….. ;0)
tradermichael
22/2/2019
08:58
TM I personally think you'll end up with the consumer part being valued at very high levels along with all the rest of the consumer goods companies. And then the rest of the group valued extremely highly too as the market will suddenly think of GSK as a world leader in HIV, vaccines with cancer coming down the pipeline too. I fully expect to be able to achieve £20 + for my holding here - which is large thanks to a far flung member of the family who's broker 60 years + ago mistakenly added an extra few 0's to the order for whatever this was back in the day : )
nimbo1
Chat Pages: Latest  785  784  783  782  781  780  779  778  777  776  775  774  Older
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200225 10:33:47